Cycloleucine is a competitive antagonist of the glycine site on the NMDA receptor (Ki = 600 µM) and an inhibitor of S-adenosyl-methionine-dependent methylation. Its cytostatic and anxiolytic-like properties make it a useful research tool for studying neurotransmission, epigenetics, and cancer biology in both cellular and animal models.